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Paracoccidioidomycosis (PCM) is a systemic granulomatous mycosis whose agent is Paracoccidioides bra-
siliensis. In the culture supernatant, the fungus expresses glycoproteins of from 13 to 148 kDa. A cell surface
glycoprotein of 43 kDa is the major antigenic component of P. brasiliensis. Another expressed glycoprotein,
gp70, is recognized by 96% of sera from PCM patients and is able to induce lymphoproliferation. Since, little
is known about this glycoprotein, we produced monoclonal antibodies (MAbs) against gp70 to isolate the
molecule from total fungus extracts and to investigate its possible role in the pathogenesis of PCM. Using these
MAbs, it was observed by confocal microscopy that gp70 is located mainly in the intracellular compartment of
the fungus, although it was also detected in the culture supernatant. Based on observations showing that gp43
has a down-regulatory effect on mouse peritoneal macrophages, we tested the effects of gp70 on their phagocytic
ability. Purified gp70 was able to inhibit the activity of macrophages through the mannose receptors and also
through the Fc receptors; the latter effect was not observed with gp43. gp70 inhibits NO and H2O2 liberation
by peritoneal macrophages in vitro, as does gp43. Results obtained with gp43 led us to hypothesize that gp70
could act as an escape mechanism for fungal establishment in primary infections. To corroborate this
hypothesis, we analyzed the effect of passive immunization of mice during infection with P. brasiliensis using
anti-gp70 MAbs. This treatment almost completely abolished granuloma formation in the lungs, suggesting
that the protein facilitates fungal establishment and progression of lesions in primary infection.
Paracoccidioidomycosis (PCM) is a deep systemic granulo-
matous mycosis whose etiological agent is Paracoccidioides bra-
siliensis, a dimorphic fungus that grows in the mycelial phase at
room temperature and in the yeast phase at 37°C or in infected
tissues. This disease is one of the most prevalent human sys-
temic mycoses in Latin America (6) and can lead to significant
mortality rates in the absence of specific therapy or in immu-
nodepressed individuals (45). The infection probably starts by
inhalation of fungal propagules that undergo differentiation
into yeast cells, the infective form of P. brasiliensis, in the lung
(35). Once established, it induces the formation of character-
istic granulomatous lesions in the lungs and lymph nodes.
These lesions are rich in viable fungi that can disseminate to
virtually all organs and tissues (38). Two main clinical forms of
the disease are recognized by the International Committee of
PCM (13), the unifocal or multifocal chronic form (AC) and
the acute or subacute form (AF). The chronic form of PCM,
which accounts for 90% of cases, mostly in adult males,
progresses slowly and can take months to years to develop
fully. Adult PCM primarily afflicts the lungs, leading to signif-
icant morbidity due to gross impairment of lung function. Sub-
sequently, the disease can disseminate to other organs and
tissues, forming secondary lesions in the mucous membranes,
skin, lymph nodes, and adrenal glands that characterize the
more advanced type of PCM. By contrast, the juvenile type of
PCM, which develops within weeks to months, is more severe,
leading to significant mortality rates due primarily to reticu-
loendothelial system organ hypertrophy. There is a pro-
nounced sex bias in P. brasiliensis infection, with a male-to-
female ratio in adult infections of up to 78:1, and the
mechanism underlying this process is thought to involve hor-
monal regulation (43).
In the culture supernatant, the fungus presents a complex
structure of proteins and glycoproteins whose molecular
masses range from 13 to 148 kDa. A 43-kDa surface glycop-
rotein is considered the main antigenic component, since it is
recognized by 100% of PCM patients’ sera (49, 50). gp43 has
been shown to bind laminin, a protein component of the ex-
tracellular matrix of mammalian tissues, and laminin-coated
yeasts have increased ability to invade and destroy tissues (52).
It has recently been demonstrated in our laboratory that gp43
down regulates lymphoproliferation and mouse peritoneal
macrophage functions, such as phagocytosis, via mannose re-
ceptors, liberation of free radicals, and the microbicidal activity
of the cells for P. brasiliensis (21).
Another glycoprotein expressed by the fungus is gp70. It was
demonstrated that only the fraction-bound extract to ConA
was reactive with sera of patients with PCM, and gp70 was one
of its components (41). It was found that gp70 is recognized by
96% of the sera from the same patients, and during chemo-
therapy of 72 patients, 55 (76%) showed a much-reduced re-
action. Also, some of the predominant components of this
molecule are polysaccharides (51). Healthy persons previously
infected by Histoplasma capsulatum reacted against gp70 but
not gp43 (12). Both gp70 and gp43 also induce lymphoprolif-
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erative responses when tested with lymphocytes from PCM
patients (3). gp70 was also detected, along with gp43, in the
urine of patients exhibiting the acute form of PCM (44). How-
ever, despite its likely importance, this fungal component of P.
brasiliensis has not yet been purified and carefully studied.
The pathophysiology of PCM is far from completely under-
stood. Nevertheless, it is well established that macrophages
constitute one of the primary mechanisms that arrest microbial
invasion. It has been demonstrated that activated macrophages
may have a central role in host resistance to systemic mycoses,
such as coccidioidomycosis (1, 2), histoplasmosis (53), blasto-
mycosis (10), and PCM (7, 9). Microscopic studies showed that
P. brasiliensis is able to multiply intracellularly in peritoneal
and pulmonary resident macrophages, indicating that they are
not fungicidal for ingested fungi (8). In contrast, lymphokine-
activated macrophages were found to be fungicidal for in-
gested P. brasiliensis (7). Identification of the fungal surface
molecules that mediate the interaction with macrophage re-
ceptors is certainly important for a understanding of the host-
invader interplay. However, the interaction between P. brasil-
iensis components and macrophages is not yet fully understood.
Cell-mediated immunity is generally acknowledged to provide
important host defense against most fungal infections. The role of
antibody-mediated immunity in host resistance is less certain (17),
despite considerable evidence that administration of some mono-
clonal antibodies (MAbs) can modify the course of infection in
mice by certain pathogenic fungi, such as Cryptococcus neofor-
mans and Candida albicans (18, 20, 27, 29, 46).
In the present study, MAbs were produced against gp70 in
order to isolate the molecule from total fungus extracts and to
investigate its influence on the phagocytic abilities of mouse
peritoneal macrophages. The effect of passive immunization of
mice before infection with P. brasiliensis using the generated
anti-gp70 MAbs was also analyzed. Treatment of mice by si-
multaneous injection of two MAbs directed to gp70 epitopes
almost abolished lung infection. As this molecule also down
regulates mouse peritoneal macrophage functions in vitro, we
propose here that MAbs, by blocking the inhibitory effect of
gp70 on phagocytes and probably on other immune effector
cells, may facilitate the clearance of the fungi from lung tissues,
thus aborting infection.
MATERIALS AND METHODS
Fungal strains. P. brasiliensis strains SS and 113 were maintained by frequent
subculturing on Sabouraud glucose agar (Difco BRL Products, Gaithersburg,
Md.). Yeast forms were grown at 35°C and subcultured every 5 days. All exper-
iments described below were performed with both fungal strains, except the assay
in vivo, in which a highly virulent isolate (Pb18) was used. To ensure the main-
tenance of its virulence, this isolate was used only after three passages in mice by
intraperitoneal inoculation.
Preparation of fungal antigens. Yeast forms of P. brasiliensis were grown on
Sabouraud glucose agar at 35°C for 3 days and transferred to 50 ml of TOM
medium prepared in our laboratory with 6.1 g of yeast extract, 16.1 g of dextrose,
15 g of casein peptone, 0.31 g of K2HPO4, 0.12 g of MgSO4  7 H2O, 0.006 g of
MnSO4  H2O, 0.006 g of NaCl, and 0.006 g of FeSO4 for 1,000 ml of distilled
H2O at 37°C on a rotating shaker as previously described (41). This preinoculum
was cultivated for 3 days and transferred into Fernbach flasks containing 500 ml
of the same medium. After 10 days of incubation at 37°C, the cells were killed by
the addition of 0.2 g of thimerosal per liter; the suspension was filtered through
filter paper, and the resulting filtered material represented the crude exoantigen.
Animals. Male and female BALB/c mice, 6 to 10 weeks old, provided by the
animal facilities of the Federal University of Sa˜o Paulo, Sa˜o Paulo, Brazil, were
used throughout this study.
SDS-PAGE and immunoblot analysis. Sodium dodecyl sulfate-polyacrylamide
gel electrophoresis (SDS-PAGE) was performed on vertical slab gels of 10% acryl-
amide according to the method of Laemmli (32) and always under reducing condi-
tions. Glycoproteins were stained with Coomassie brilliant blue, silver nitrate, or
periodic acid-Schiff. Immunoblotting was performed as described elsewhere (48).
Immunization protocols. In the first schedule of immunization, 6-week-old
BALB/c mice were intraperitoneally injected every 2 weeks for 4 months with
macerated polyacrylamide gel containing 70-kDa glycoprotein (gp70). In a second
schedule, mice were subcutaneously immunized every 2 weeks with 50 g of gp70
(purified through MAbs obtained in the first fusion) in phosphate-buffered saline
(PBS), incorporated in Freund’s complete adjuvant for the first injection and in
incomplete Freund’s adjuvant for the subsequent injections. Injections were always
made in four different sites in the axillary and inguinal regions in a final volume of
100 l per site. Before each immunization, the mice were bled through the ocular
plexus, and the serum was separated by centrifugation and stored at 20°C. Final
immunization was done intravenously 2 days before cell fusion.
Fusion protocols. Cells of the murine myeloma line sp2 were fused with spleen
cells from immunized mice according to the method of Lopes and Alves (34). For
the first fusion, hybridomas were distributed in 48-well plates (Costar Corp.,
Cambridge, Mass.), and 10 days postfusion, the colonies were screened by im-
munoblotting, as described below. For the second fusion, hybridomas were
distributed in 96-well plates (Costar), and the screening was done by enzyme
immunoassay (EIA) as described elsewhere (42). After cell cloning by limiting
dilution and expanding of the positive clones, large amounts of antibodies were
obtained from the ascites fluid induced in BALB/c mice injected with Pristane
(Sigma) before the inoculation of hybridoma cells.
Antibody screening by immunoblotting. Exoantigens were fractionated by
SDS-PAGE with 10% acrylamide under reducing conditions. The proteins were
then transferred by electrophoresis to nitrocellulose membranes. Fragments of
nitrocellulose membranes containing gp70 were cut in small pieces and distrib-
uted in 48-well plates (Costar). After free sites were blocked with PBS containing
5% skim milk, 200 l of supernatants from the hybridoma cultures was added to
each well. After 1 h of incubation at room temperature, the wells were washed
five times for 5 min each time with PBS containing 0.1% Tween 20 (Sigma) and
treated with affinity-purified peroxidase-conjugated goat anti-mouse immuno-
globulin (Ig) (Bio-Rad) for 1 h at room temperature. The wells were washed five
times with PBS containing 0.1% Tween 20. The presence of reactive IgG was
tested by the addition of 4-chloro-naftol in 50 mM Tris buffer, pH 6.8, metanol,
and H2O2 and terminated with distilled water.
gp70 purification. Exoantigen of P. brasiliensis strains SS and 113, prepared
separately as described above, was used as the antigen source. Purification of
gp70 was performed by affinity chromatography in a Sepharose CNbr column
coupled with MAb 1A7C5F11 (from now on called C5F11) directed to gp70
epitopes. This MAb was purified from both culture supernatants and ascites
fluids by affinity chromatography in a protein G column. Ig isotyping was per-
formed with a mouse antibody isotyping kit (Gibco) according to the manufac-
turer’s instructions.
The gp70 concentration was determined by the Bradford method (4). All steps
of gp70 purification were monitored by SDS-PAGE.
ELISA. Enzyme-linked immunosorbent assays (ELISAs) were carried out as
described elsewhere (42). Briefly, plates were coated with 1 g of purified
gp70/ml in PBS, 50 l per well, for 1 h at 37°C. Blocking of free sites on plastic
was done with 5% PBS– milk for 1 h at 37°C. Anti-gp70 MAbs were added in
various concentrations (5, 10, 20, and 40 g/ml in PBS; 50 l per well). After 1 h,
the plates were incubated with anti-mouse IgG (horseradish peroxidase conju-
gated in PBS; 50 l per well) (Bio-Rad). Between the incubation steps, the wells
were washed three times with PBS– 0.1% Tween 20– 0.7% gelatin. After incu-
bation for 1 h at 37°C and washing of the wells, substrate solution (1 mg of
O-phenylenediamine in 5 ml of 0.1 M citrate-phosphate buffer [pH 5.0] plus 10
l of 30% H2O2) was added to each well, and the reaction was interrupted by the
addition of 50 l of 2 N H2SO4 per well. Optical densities were read in a
Multiskan MCC/340 II EIA reader at 492 nm.
Recognition of gp70 by MAbs. To investigate whether gp70 was recognized
only when purified or also in living fungi, an EIA was devised. Live fungi were
bound to the plastic substrate through panning by human polyclonal anti-P.
brasiliensis serum. On the side, purified gp70 was directly bound to the surface.
After washing and quenching of the plastic surface as described above, the
reaction was developed with mouse anti-gp70 MAbs.
Inhibition assay. In order to ascertain the natures of gp70 epitopes to which
MAbs were directed, whether carbohydrate or protein, polyvinyl plates were
coated with purified gp70 and incubated with 20 g of anti-gp70 MAbs/ml after
being previously incubated for 1 h under constant agitation with 25, 50, and 100
mM solutions of mannose, galactose, glucose, and -methyl-D-mannopyranoside.
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After this incubation period, the concentrations of IgG in these preparations
were determined as previously described.
IEF. Isoelectric focusing (IEF) was performed with the Pharmacia LKB (Upp-
sala, Sweden) PhastSystem apparatus. One microgram of affinity-purified gp70
from P. brasiliensis SS and/or 113 was submitted to IEF analysis using PhastGel
IEF (Pharmacia) in a pH range of 3 to 9 according to the manufacturer’s
instructions. Standard markers for isoelectric point (pI) determination of pro-
teins in the same pH range (Pharmacia) were used. gp70 was developed by silver
staining (PhastGel Silver kit; Pharmacia).
Confocal microscopy. Yeast forms of P. brasiliensis from 5-day-old cultures
grown in yeast extract-peptone-dextrose broth medium were fixed for 60 min
with 0.5 ml of 3.5% formaldehyde in PBS and washed as before. The pellets were
resuspended in 0.1 ml of PBS, and 10 l of each cell suspension was applied to
the microwells of fluorescence slides.
The cells were incubated with 50 mM amonium choride for 60 min, followed
by 1 h of incubation with 0.1% Triton X-100 diluted in PBS– 0.2% gelatin.
Anti-gp70 MAbs were added at a concentration of 50 g/ml diluted in PBS–0.2%
gelatin and incubated for 2 h. Finally, fluorescein-conjugated secondary antibody
was added together with DAPI (4,6-diamidino-2-phenylindole)-stained nuclei
for 60 min of incubation. All steps were followed by constant washing with PBS.
The slides were mounted with 5% buffered glycerol to minimize bleaching.
Images of DAPI-stained cells were observed in a Bio-Rad 1024 UV confocal
system attached to a Zeiss Axiovert 100 microscope, using a 40 numerical-
aperture 1.2 plan-apochromatic differential interference contrast water immer-
sion objective. All images were collected by Kalman averaging at least every eight
frames (512 by 512 pixels), using an aperture (pinhole) of 2 mm.
Peritoneal macrophages. Peritoneal macrophages were used as representa-
tives of nonspecific response. Any differences from alveolar macrophages could
not be checked due to the very small amount of gp70 available. Cells were
collected from the abdominal cavities of BALB/c mice by repeated washing with
5 ml of fresh RPMI 1640. Peritoneal macrophages from all of the mice were
pelleted by centrifugation at 390  g rpm for 4 min and then pooled. The
peritoneal macrophages were resuspended in R10 medium and distributed in
wells of tissue culture plates. The cultures were incubated at 37°C in 5% CO2 for
1 h. Nonadherent cells were removed by aspiration, and RPMI 1640 with 10%
(vol/vol) heat-inactivated fetal bovine serum (R10) was added to the adherent
monolayers.
For the phagocytic assays, 5  105 peritoneal macrophages were resuspended
in 0.5 ml of R10 and dispensed in 24-well tissue culture plates (Costar) contain-
ing round glass coverslips in the bottom. Adherent monolayers were rinsed with
0.5 ml of R10. The macrophages were maintained in culture for 72 h.
To determine NO and H2O2 liberation by these cultures, 2  105 peritoneal
FIG. 1. Silver-stained gel from SDS-PAGE demonstrating bovine serum albumin (67 kDa) used as standard (lanes 1) and purified gp70 (lanes
2). (A) Periodic acid-Schiff staining showing exoantigen (lane 1) and purified gp70 (lane 2). (B) IEF comparing gp70 and gp43. Lane 1, the pI of
gp70 is 3.00; lane 2, four isoforms of gp43 are seen; lane 3, pI standards.
FIG. 2. ELISAs of MAbs showing different levels of reactivity with gp70. The negative control (5% skim milk and unrelated MAb) and positive
control (mouse polyclonal anti-gp70 serum) are not shown. MAb 2B8A6D2 does not react in ELISA, probably because it recognizes a different
spatial conformation of gp70.
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cells in 0.15 ml of R10 were distributed in wells of a 96-well tissue culture plate.
Adherent cell monolayers were rinsed with 0.05 ml of R10, and the macrophages
were maintained in culture for 48 h.
Phagocytic assays. Phagocytic assays were done with macrophages maintained
in culture for 72 h. gp70 dissolved in R10 medium at different concentrations (25,
50, and 100 g/ml) was added to macrophage cultures. After 5 min of incubation
with gp70, zymosan particles (10 mg/ml) were added to the cultures. After 60
min, the coverslips were vigorously washed with PBS and fixed in 2% glutaral-
dehyde. These preparations were analyzed under phase-contrast microscopy.
The same protocol was used to evaluate the influence of gp70 on the uptake
of sheep red blood cells previously opsonized with subagglutinating doses of
rabbit IgG anti-sheep red blood cells at 37°C for 1 h. The preparations were
stained by Hema 3 (24) and analyzed by optical microscopy. The viability of the
macrophages was always checked by trypan blue exclusion.
An average of 200 phagocytic cells were counted in the control group to
represent 100%.
NO determination. Peritoneal macrophage cultures as described above were
incubated with different concentrations of gp70 (0.125, 0.25, 0.5, and 1 g/ml),
and after 48 h, the concentration of NO2 in the culture supernatant was mea-
sured with the Griess reagent (1% sulfanilamide, 0.1% naphthylethylenediamine
dihydrochloride, 25% H3PO4). All assays were done in triplicate. The concen-
tration of gp70 used was the result of previous experiments in our laboratory.
H2O2 determination. Peritoneal-macrophage cultures as described above were
stimulated with 10 ng of lipopolysaccharide (LPS)/ml and 10 IU of gamma
interferon (IFN-	) or unstimulated and were treated with 1 g of gp70/ml or left
untreated. After 2 days, a phenol red solution (PBS, 5 mM dextrose, 50 g of
horseradish type II, 0.28 mM phenol red) was added to the cells for 1 h at 37°C,
and the reaction was stopped by the addition of 10 l of 1 N NaOH solution. A
standard curve for the determination of the H2O2 concentration in the experi-
mental tests was constructed using H2O2 solution varying from 0.5 to 4 nmol.
Absorbance was measured at 620 nm in a microtiter plate reader (MR 4000;
Dynatech Chantilly).
Passive immunization. Five groups of eight male BALB/c mice each (8 to 10
weeks old) were used. All groups were infected intratracheally with the Pb18
strain of P. brasiliensis, as previously described (16), and received different
treatments by the intravenous route. The first group received 100 l of PBS, the
second group received 100 g of an irrelevant MAb (anti-CEA [carcinoembry-
onic antigen]), the third group received 100 g of MAb 1B7D6 (from now on
called B7D6), the fourth group received 100 g of MAb C5F11, and the fifth
group received 100 g each of MAbs B7D6 and C5F11. To ensure the mainte-
nance of the concentrations of antibodies in serum throughout the infection, the
MAbs were administered 3 days before and every 3 days after infection over a
period of 45 days.
CFU determination. Mice of each experimental group were sacrificed after 45
days of infection, and the numbers of viable microorganisms in the lungs, liver,
and spleen were determined by the CFU method as previously described (3). The
results of CFU studies were confirmed by two identical protocols.
Histopathology. Fragments of lungs, livers, and spleens from mice of the
different experimental groups were fixed in 10% formalin for 24 h and embedded
in paraffin. Tissue sections (5 m thick) were obtained and stained with hema-
toxylin and eosin.
Statistics. Statistical comparisons were made by analysis of variance and the
Tukey-Kramer test. All values were reported as the mean 
 standard error of the
mean.
FIG. 3. Plates were coated with gp70 and incubated with B7D6
(A) and C5F11 (B), previously incubated for 1 h with carbohydrates.
FIG. 4. Confocal microscopy with anti-gp70 MAb revealed with
mouse anti-IgG–fluorescein isothiocyanate (FITC). (A) gp70 labeling.
(B) Double staining. Nuclei labeled with DAPI are blue, and gp70 is
orange. (C) Negative control; absence of gp70 using only anti-mouse–
FITC.
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RESULTS
MAb generation and antigen purification. After cloning and
selection, five stable MAbs that specifically recognized gp70
from P. brasiliensis were obtained. MAbs 1A7C5F5F11 and
2B8A6D2 were of the IgG1 isotype, and MAbs 1E6B1F4,
1E6B8F3, and 2E7A2C4 were of the IgM isotype (all  light
chains). The IgG1 MAb C5F11 was coupled to Sepharose 4B
CNbr and used to isolate the antigen by affinity chromatogra-
phy. gp70 was purified from exoantigens produced by strains
SS and 113 (Fig. 1A and B).
In order to investigate whether gp70 expressed different
isoforms, an IEF assay was carried out. The results showed that
the isolated protein presented a single isoform with a pI of 3.4.
Conversely, gp43, used here for comparison, has several iso-
forms with pIs ranging from 5.85 to 6.8 (Fig. 1C).
In another set of fusion experiments, one MAb directed to
epitopes of gp70, B7D6, was obtained and characterized as IgG1.
The binding of MAbs to gp70 was evaluated by EIA (Fig. 2).
gp70 was also recognized by the MAbs in live fungi adhering
to the plastic surface by human polyclonal anti-P. brasiliensis
serum (data not shown).
Inhibition assays. To analyze whether anti-gp70 MAbs bind
the 70-kDa glycoprotein through epitopes composed of peptides
or carbohydrates, inhibition assays were performed. The results
showed that MAb C5F11 binds to a peptide epitope, whereas
MAb B7D6 is partially inhibited by carbohydrates (Fig. 3).
Confocal microscopy. Using two anti-gp70 antibodies, B7D6
and C5F11, confocal microscopy was employed to determine the
localization of gp70 in the fungus in the yeast phase. It was
observed that gp70 was present in the intracellular milieu (Fig. 4).
Inhibition of phagocytosis in vitro. To investigate whether
gp70 influences phagocytosis through the mannose receptor,
zymosan particles (10 mg/ml) were added to peritoneal-mac-
rophage cultures previously supplied with different concentra-
tions of gp70 (25, 50, and 100 g/ml). The results showed that
purified gp70 inhibited phagocytosis of zymosan particles in a
dose-dependent manner (Fig. 5). The maximal inhibition of
phagocytic activity was obtained with 100 g of gp70/ml.
FIG. 5. Influences of different gp70 concentrations on phagocytosis
of zymosan particles (10 mg/ml) by BALB/c mouse peritoneal macro-
phages. (A) Percentages of phagocytic cells (100% corresponds to 200
phagocytic cells). *, significantly different (P  0.001) from controls.
(B) Number of particles taken up per phagocytic cell. *, P  0.05; **,
P  0.001 (significantly different from control). The error bars indicate
standard errors.
FIG. 6. Influences of different gp70 concentrations on phagocytosis
of opsonized sheep red blood cells by BALB/c mouse peritoneal mac-
rophages. (A) Percentages of phagocytic cells (100% corresponds to
200 phagocytic cells). (B) Number of particles taken up per phagocytic
cell. *, statistically significant (P  0.001) compared to controls. The
error bars indicate standard errors.
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As shown in Fig. 6, gp70 also influences phagocytosis
through the Fc receptor. At a concentration of 25 g of gp70/
ml, a marked inhibition in the uptake of opsonized sheep red
blood cells was observed.
NO and H2O2 release. The influence of gp70 on NO and
H2O2 release by cultured macrophages was investigated. The
results showed that gp70 inhibited basal NO production by
nonactivated peritoneal macrophages, with an initial concen-
tration of 0.125 g/ml (Fig. 7). Similarly, gp70 also inhibited
H2O2 production by peritoneal macrophages activated or not
with LPS and IFN-	 (Fig. 8).
Passive immunization. To evaluate whether administration
of IgG1 anti-gp70 MAbs could alter the course of PCM,
BALB/c mice were infected intratracheally with P. brasiliensis
and intravenously treated with anti-gp70 MAbs. After 45 days
of infection, the average time for the establishment of infection
by yeast cells, the number of CFU in the lungs of animals
treated with MAb B7D6 was similar to that in controls. Re-
duction in the number of CFU in mice treated with MAb
C5F11 was observed, but a significant decrease in the number
of CFU was obtained only with the group that received con-
comitant administration of both MAbs C5F11 and B7D6 (Fig.
9). Histopathology of lungs from infected and treated animals
confirmed the CFU results. The lungs of control animals pre-
sented an inflamed parenchyma with a large cellular infiltrate,
mainly of the mononuclear type, and well-organized granulo-
mas with great numbers of viable yeast cells, most of them
within the cytoplasm of phagocytic cells. Similar results were
observed in the lungs of mice treated with an irrelevant MAb.
The lungs of animals that received MAb B7D6 presented a
minor reduction in parenchyma inflammation and granulomas.
Mice treated with C5F11 showed well-preserved parenchymas
with large peribronchial cellular infiltrates and did not present
yeast cells or granuloma formation. The lung parenchymas of the
animals treated with both the antibodies B7D6 and C5F11 were
similar to those of the C5F11 group, but moderate peribronchial
cellular infiltrate was not regularly observed (Fig. 10).
The histopathology and CFU of livers and spleens of all
treated mice, including control animals, did not show the pres-
ence of fungus (data not shown).
DISCUSSION
The agent of PCM, P. brasiliensis, like many other eukaryotic
parasites, expresses several antigenic molecules that may be
recognized by antibodies produced by human patients or raised
in immunized laboratory animals. The chemical natures of
these components and their participation in the pathophysiol-
ogy of the fungus are poorly known, since very few molecules
have been isolated in pure form and subsequently character-
ized.
gp43 is the main purified diagnostic specific antigen when
used in liquid phase serologic tests (6), since it is recognized by
100% of PCM patients’ sera (49, 50). MAbs against gp43 have
been used in a capture immunoassay for the specific detection
of antibodies in patients with PCM (11). gp43 has been shown
to bind laminin, a protein component of the extracellular ma-
trix of mammalian tissues, and laminin-coated yeasts have in-
creased ability to invade and destroy tissues. Based on these
data, gp43 on the surfaces of yeast cells has been proposed to
act as a laminin receptor (52). A T-cell epitope in gp43 has
been mapped to a 15-residue sequence, and immunization with
the corresponding oligopeptide elicited a protective response
against virulent P. brasiliensis (47). Furthermore, DNA-based
vaccination using the gp43 gene led to protective immunity
against P. brasiliensis in BALB/c mice (40). It has recently been
demonstrated in our laboratory that gp43 down regulates
mouse peritoneal-macrophage functions, such as phagocytosis,
via mannose receptors, liberation of free radicals, and the
microbicidal activity of these cells for P. brasiliensis (21).
In addition to gp43, another glycoprotein, gp70, is recognized
by 96% of the sera from untreated patients with PCM (12).
Although it cross-reacts with sera from patients with other myco-
FIG. 7. NO release by BALB/c mouse peritoneal macrophages in
culture supernatants after 2 days of treatment with gp70. *, signifi-
cantly different (  0.001) from control. The error bars indicate
standard errors.
FIG. 8. H2O2 release by BALB/c mouse peritoneal macrophage
culture supernatants after 2 days with or without stimulation with 10 ng
of LPS/ml and 10 IU of IFN-	 and with or without treatment with 1 g
of gp70/ml. *, significant (  0.001) compared with control. The error
bars indicate standard errors.
FIG. 9. CFU from lungs of BALB/c mice after 45 days of infection
with 106 cells of P. brasiliensis strain Pb18 and intravenous treatment
with anti-gp70 MAbs (100 g) or irrelevant MAb. *, significant ( 
0.05) compared to controls. The error bars indicate standard errors.
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ses by ELISA, it seems to be a valuable marker of active PCM in
immunoblotting reactions. gp70 and gp43 induce lymphoprolif-
erative responses when tested with lymphocytes from PCM pa-
tients (3), and gp70 is also detected, along with gp43, in the urine
of patients (44). Otherwise, little is known about the 70-kDa
glycoprotein, and the purpose of the present work was to attempt
to better understand its role in PCM.
We have produced and characterized six MAbs against gp70,
three of which had their isotypes established as IgG1() and
the others as IgM(). We noticed that the IgG1 MAb C5F11
reacted with peptide sequences of gp70, while the IgG1 MAb
B7D6 could be inhibited by carbohydrates. Immunoblotting
assays revealed that all MAbs reacted with gp70 and in EIAs,
and only one of the MAbs (2B8A6D2) did not recognize gp70.
This antibody probably binds to different configurations of the
glycoprotein, although some variations in sensitivity may de-
pend on the assay used.
gp70 was successfully purified from exoantigen, as seen by
silver-stained SDS-PAGE or periodic acid-Schiff staining. We
also observed that gp70 has only one isoform, with an acid pI
of 3.4, thus differing from gp43, which has several isoforms with
basic pIs ranging from 6.85 to 5.8. Confocal microscopy anal-
ysis showed that gp70 is predominantly located in the intracel-
lular compartment of the fungus, although a small amount was
also detected in the culture supernatant. The same epitope of
gp70 could be detected in both live fungi and purified protein,
showing that despite being mainly a cytoplasmic protein, it is
also expressed on the fungus surface (data not shown). Use of
purified antigens led to an increased titer of antibodies, as
detected by ELISA in hybridoma culture supernatants and
mouse ascites fluid, suggesting that their use in serologic tests
could increase the sensitivity for antibody detection, and thus,
that gp70 could represent a possible target for immunodiag-
nostic studies.
FIG. 10. Histopathology of lung sections of P. brasiliensis-infected BALB/c mice 45 days after infection. (A) Control mice show well-organized
granulomas (arrows) and a high number of yeast cells (magnification, 100). (B) Granulomatous lesion from control group showing intact fungi
and typical macrophages and epithelial cells (magnification, 400). (C) Mice treated with MAb B7D6 show smaller, well-organized granulomas
(arrows) with a high number of yeast cells (magnification, 100). (D and E) Mice treated with MAb C5F11 (D) and mice treated concomitantly
with both MAbs C5F11 and B7D6 (E) show absence of both yeast cells and granulomas (magnification, 400). (F) Nongranulomatous lung from
both MAb-treated mice, predominantly composed of a mononuclear infiltrate in which fungi are not seen (magnification, 100).
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These MAbs could also be useful for the detection of the
epitopes involved in the interaction of the antigen with cells
and components of the biological system being studied. The
main targets of this investigation were macrophages, the first
line of the host’s defense. The mononuclear phagocytic system
constitutes an important effector mechanism in the natural and
adaptive immune responses against several pathogens. It has
been suggested that macrophages play a fundamental role in
resistance to P. brasiliensis (31). This function depends upon
their state of activation, which leads to microbicidal activity.
Previous studies have demonstrated that murine peritoneal
cells activated by IFN-	 exert a fungicidal effect on both the
yeast and conidial forms of P. brasiliensis (5, 14, 15). Based on
these findings, in this study we tested the effect of gp70 on the
phagocytic ability of mouse peritoneal macrophages. It was
demonstrated that purified gp70, at from 25 to 100 g/ml, was
able to inhibit phagocytosis of zymosan particles in a dose-
dependent fashion. This inhibition probably occurred because
the predominant components of gp70 are polysaccharides,
which bind to mannose receptors on the surfaces of macro-
phages, thus blocking the binding of zymosan particles and
consequently their phagocytosis. gp43 has a similar effect on
the inhibition of phagocytosis of zymosan particles by macro-
phages (21).
We also observed that gp70 inhibited phagocytosis of opso-
nized sheep red blood cells, although not in a dose-dependent
manner. This result supports the notion that gp70 inhibits the
activity of phagocytic macrophages not only through the man-
nose receptor but also through the Fc receptor, in which it
differs from gp43, which does not have the latter effect (21).
Macrophages activated by IFN-	, tumor necrosis factor al-
pha, or LPS produce two kinds of reactive products that char-
acterize their cytotoxic activity: reactive oxygen intermediates
and reactive nitrogen intermediates. Nitric oxide, one of the
most important reactive nitrogen intermediates, is responsible
for the cytotoxic effect exerted on a variety of microorganisms,
including parasites such as Schistosoma mansoni (30), and sev-
eral fungi, such as C. neoformans (22) and H. capsulatum (33,
37). Hydrogen peroxide is one of the most important reactive
oxygen intermediates. Since gp70 inhibits phagocytosis, we an-
alyzed the effect of this glycoprotein in the liberation of these
products, and we noticed that, like gp43, the 70-kDa glycop-
rotein decreases the release of both NO and H2O2 by macro-
phages (21).
The use of vaccines that stimulate humoral or cellular im-
munity can theoretically elicit protection against fungal patho-
gens. There is conclusive evidence that humoral immunity can
modify the course of infection of some pathogenic fungi. C.
neoformans has a polysaccharide capsule which is essential for
its virulence, and MAbs reactive against it can protect against
experimental cryptococcosis (19, 23, 36). It was also demon-
strated that an IgG3 MAb was not protective in various mouse
models of cryptococcal infection, while an IgG1 MAb signifi-
cantly prolonged survival (39, 54). However, when the nonpro-
tective IgG3 MAb was switched to IgG1, an increase of anti-
body protective efficacy occurred.
For another fungus, C. albicans, antibodies to cell wall poly-
saccharides were protective against experimental disseminated
candidiasis (25, 28). Also, it has been shown that the efficiency
of antibody protection depends on epitope specificity (26).
These studies demonstrate a complex relationship among the
efficacy of antibody protection, epitope specificity, and isotype.
In this paper, we analyzed the effect of passive immunization
of mice infected with P. brasiliensis using the generated anti-
gp70 IgG1 MAbs. A significant reduction in the number of
CFU in the lungs was observed when MAbs C5F11 and B7D6
were administered concomitantly, thus confirming results seen
with CFU. Histopathology of lung sections showed improve-
ment of the infection with a reduction in the number of fungus
particles and granulomas within the organ.
Despite gp43 being considered the main antigenic compo-
nent of P. brasiliensis, the effect of passive immunization using
the anti-gp43 IgG2a MAbs did not produce similar results
(unpublished data).
The nature of the mechanisms which underlie the abortion
of lung infection in mice treated with MAbs directed to gp70
epitopes is a complex issue. Nevertheless, two non-mutually
exclusive hypotheses could be put forward. First, antibodies
could be reacting with gp70 on the fungus surface, thus facil-
itating phagocytosis and killing of the fungal particles. Second,
by neutralizing the macrophage-down-regulatory effect of the
protein, macrophages could be free to eliminate the parasite.
In both proposals, these mechanisms would work in the begin-
ning of the infection, since we are far from understanding the
mechanisms which determine the progression of infection in
PCM and other types of infectious diseases. Negative results
obtained with MAbs directed to gp43 could be due to the
existing isoforms of the molecule, impairment in the neutral-
ization of its effects, or opsonization of the fungal particles.
Antibodies have been considered the hallmarks of a more
severe disease in PCM, while protection has always been at-
tributed to cellular immune response. Here, it is shown for the
first time that antibodies by themselves can abrogate establish-
ment and development of the disease. Although these mech-
anisms have not yet been discovered, it is possible to suppose
that vaccination with gp70 or its active fragments could provide
an armamentarium, not yet available, to control the incidence
of PCM in areas of endemicity.
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